Steric disruption of EGFR oligomerization overcomes therapy resistance in non–small cell lung cancer

Journal:

Science Advances

Published:

2025-12-05

DOI:

10.1126/sciadv.ady7032

Affiliations:

5

Authors:

4

Go to article

Institutions	Authors	Share
Stanford Medicine, United States of America (USA)	1.166667	0.29
Seoul National University (SNU), South Korea	1.000000	0.25
Korea Advanced Institute of Science and Technology (KAIST), South Korea	1.000000	0.25
Stanford University, United States of America (USA)	0.833333	0.21

Interested in Oncology and Carcinogenesis?